This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Intravenous methotrexate at a dose of 1 g/m2 incorporated into RCHOP prevented CNS relapse in high‐risk DLBCL patients: A prospective, historic controlled study. Issue 4 (22nd January 2020)
Record Type:
Journal Article
Title:
Intravenous methotrexate at a dose of 1 g/m2 incorporated into RCHOP prevented CNS relapse in high‐risk DLBCL patients: A prospective, historic controlled study. Issue 4 (22nd January 2020)
Main Title:
Intravenous methotrexate at a dose of 1 g/m2 incorporated into RCHOP prevented CNS relapse in high‐risk DLBCL patients: A prospective, historic controlled study